3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
4
NIH
1
NETWORK
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Osteosarcoma
2
Stomach Neoplasms
1
Sarcoma
1
Prostatic Neoplasms
1
Lung Neoplasms
1
Hepatoblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Esophageal Neoplasms
1
Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Medullary
1
Carcinoma, Hepatocellular
1
Adenocarcinoma Of Esophagus
1
Interventions
Fluorouracil
12
Cisplatin
12
Leucovorin
9
Paclitaxel
8
Radiotherapy
6
Oxaliplatin
5
Capecitabine
5
Irinotecan
4
Gastrectomy
3
Epirubicin
3
Trastuzumab
2
Taxes
2
Surgical Procedures, Operative
2
Platinum
2
Neoadjuvant Therapy
2
Docetaxel
2
uridine triacetate
1
sargramostim
1
pertuzumab
1
carfilzomib
1
Watchful Waiting
1
Vorinostat
1
Sorafenib
1
Ramucirumab
1
Radiosurgery
1
Preoperative Exercise
1
Polymerase Chain Reaction
1
Ondansetron
1
Lithium
1
Lapatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Stomach Neoplasms
×
Sorafenib
×
Clear all
NCT01158287
2014-12-31
Sorafenib. ICORG 06-41, V4
Cancer Trials Ireland
Phase 2
Completed
54 enrolled